Atrial natriuretic peptide engrafted antibodies
US-2025361282-A1 · Nov 27, 2025 · US
This page is not indexed by search engines while we improve data quality.
Tebbe Jan patents
Tebbe Jan is listed as an inventor on 32 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Tebbe Jan |
| Total patents | 32 |
| First publication | Nov 12, 2015 |
| Latest publication | Nov 27, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Novel rna-programmable endonuclease systems and uses thereof
US-2025320477-A1 · Oct 16, 2025 · US
Brain natriuretic peptide engrafted antibodies
US-12390508-B2 · Aug 19, 2025 · US
C-type natriuretic peptide engrafted antibodies
US-2025236654-A1 · Jul 24, 2025 · US
Atrial natriuretic peptide engrafted antibodies
US-12331094-B2 · Jun 17, 2025 · US
RNA-programmable endonuclease systems and uses thereof
US-12203110-B2 · Jan 21, 2025 · US
INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING
US-2024317847-A1 · Sep 26, 2024 · US
INHIBITORS OF IL-11 OR IL-11Ra FOR USE IN THE TREATMENT OF ABNORMAL UTERINE BLEEDING
US-2024124572-A1 · Apr 18, 2024 · US
Site specific homogeneous with KSP inhibitors
US-11806404-B2 · Nov 7, 2023 · US
RNA-programmable endonuclease systems and their use in genome editing and other applications
US-11578323-B2 · Feb 14, 2023 · US
Recent patents
Latest publications not already listed above.
HPPD variants and methods of use
US-11371056-B2 · Jun 28, 2022 · US
Humanized monoclonal antibodies against activated protein c and uses thereof
US-RE49099-E · Jun 7, 2022 · US
HPPD variants and methods of use
US-11180770-B2 · Nov 23, 2021 · US
Site specific homogeneous with ksp inhibitors
US-2021252161-A1 · Aug 19, 2021 · US
Brain natriuretic peptide engrafted antibodies
US-2021147504-A1 · May 20, 2021 · US
Atrial natriuretic peptide engrafted antibodies
US-2021139555-A1 · May 13, 2021 · US
Site specific homogeneous with KSP inhibitors
US-10973923-B2 · Apr 13, 2021 · US
C-type natriuretic peptide engrafted antibodies
US-2021079056-A1 · Mar 18, 2021 · US
Novel rna-programmable endonuclease systems and uses thereof
US-2021054353-A1 · Feb 25, 2021 · US
Novel rna-programmable endonuclease systems and their use in genome editing and other applications
US-2020385720-A1 · Dec 10, 2020 · US
Hppd variants and methods of use
US-2020239905-A1 · Jul 30, 2020 · US
HPPD variants and methods of use
US-10597674-B2 · Mar 24, 2020 · US
Hppd variants and methods of use
US-2020063155-A1 · Feb 27, 2020 · US
Site specific homogeneous with ksp inhibitors
US-2019262463-A1 · Aug 29, 2019 · US
Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
US-RE47150-E · Dec 4, 2018 · US
Hppd variants and methods of use
US-2018208937-A1 · Jul 26, 2018 · US
Anti-c4.4a antibodies and uses thereof
US-2017158775-A1 · Jun 8, 2017 · US
Humanized monoclonal antibodies against activated protein C and uses thereof
US-9657111-B2 · May 23, 2017 · US
Antibodies to TNFα
US-9534046-B2 · Jan 3, 2017 · US
Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
US-9309324-B2 · Apr 12, 2016 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Bayer Healthcare Llc | 10 |
| Bayer Ag | 8 |
| BASF Agricultural Solutions Seed US LLC | 5 |
| Crispr Therapeutics Ag | 5 |
| Bayer Pharma AG | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/565 | 15 |
| C07K2317/24 | 12 |
| A61K2039/505 | 12 |
| C07K2317/567 | 10 |
| A61P35/00 | 7 |